Education

 
 
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences reverse logo

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences reverse logo

 
 

Ph.D. - Neuroimmunology

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences - Houston, Texas

 
  • August 2016 - May 2022

  • Cumulative GPA: 4.000

 
Texas Tech University Health Sciences Center full color logo

Texas Tech University Health Sciences Center full color logo

 

MS - Biotechnology

Texas Tech University Health Sciences Center - Abilene, Texas

 
  • August 2014 - May 2016

  • Cumulative GPA: 3.942

Angelo State University Logo

Angelo State University Logo

 

BS - Biochemistry

Angelo State University - San Angelo, Texas

Minor: Biology for Biochemistry majors

 
  • January 2010 - May 2014

  • Cumulative GPA: 3.724 Magna Cum

 

Research Experience

 

ILC2s polarize microglia to a reparative, M2-like phenotype

A picture of Dr. John J Kopchick and Alexis S. Mobley in front of her scientific poster about ILC2s and phenotypic changes in aging and sex differences during Graduate Student Research Day - 2019 in Houston, Texas.

A picture of Dr. John J Kopchick and Alexis S. Mobley in front of her scientific poster about ILC2s and phenotypic changes in aging and sex differences during Graduate Student Research Day - 2019 in Houston, Texas.

Mentors: Drs. Jaroslaw “Jarek” Aronowski and Louise D. McCullough

The greatest risk factor for stroke is aging, which leads to a dysregulation of inflammatory responses throughout the body. Group 2 innate lymphoid cells (ILC2s) help balance inflammation in young mice but have not been investigated in aging. My thesis investigates how ILC2s and brain immune cells, called microglia, communicate and how ILC2s can control microglia to be reparative in aging and age-related diseases such as stroke.

 

Development of a high-throughput assay to screen antibody and T cell selectivity/specificity against the peptide/human leukocyte antigen complex

A picture of Alexis S. Mobley in front of her scientific poster about the development of high-throughput assays to screen antibody and T cell selectivity/specificity against the peptide/human leukocyte antigen complex during TTUHSC Graduate Research…

A picture of Alexis S. Mobley in front of her scientific poster about the development of high-throughput assays to screen antibody and T cell selectivity/specificity against the peptide/human leukocyte antigen complex during TTUHSC Graduate Research Day - 2016 in Lubbock, Texas.

Mentors: Drs. Devin B Lowe and Jon A Weidanz

Immunotherapy is a first-line strategy against several forms of cancer and a common Y-shaped protein, called antibodies, is currently used as a therapeutic for cancer and other diseases. All cells, except red blood cells, let the immune system know they are healthy or infected using a signal called the peptide/human leukocyte antigen (HLA), and our group have developed an antibody that can recognize this signal and bring either drugs or immune cells to specific diseased targets. Unfortunately, many therapeutics fail in clinical trials, highlighting the need for more rigorous pre-clinical testing. During my master’s degree, I developed a platform to analyze how our antibodies bind these peptide/HLA complexes using labeled and unlabeled techniques to identify the most selective antibodies, thereby decreasing off-target effects and increasing patient safety.

 

Isolation, sequence, and characterization of p53 mRNA in various bat species

ASU Poster OK.jpg

A picture of Alexis S. Mobley in front of her scientific poster about the isolation, sequence, and characterization of p53 mRNA in various bat species during the Beta Beta Beta Biological Honor Society Regional Meeting Poster Session - 2014 in Kingston, Oklahoma.

Mentor: Dr. Loren K Ammerman

Bats live substantially long lives compared to other mammals of similar size but do not develop cancer. Tumor suppressors are one mechanism meant to protect the body from cancer. p53 is a commonly researched tumor suppressor with many different variants of this protein. My undergraduate research investigated the message that leads to the protein (mRNA) extracted from bats that I helped capture and preserve and mRNA sequences found in a database to compare p53 sequences between bats and other mammals. I discovered a unique insertion in 4 of the 5 bats in my alignment, though the biological importance of this region remains to be determined.

 Certifications

 
  • Health and Human Services Regulations | U.S. Department of Health and Human Services | March 2021

  • Human Subjects Research | U.S. Department of Health and Human Services | March 2021

  • Independent Review of Research | U.S. Department of Health and Human Services | March 2021

  • Institutional Review Board | U.S. Department of Health and Human Services | March 20201

  • International Harmonization Conference E6(R2) Good Clinical Practice | TransCelerate BioPharma Inc. | March 2021

  • Phlebotomy | Central Texas Phlebotomy Institute, LLC. | April 2017